McKesson Net Worth 2010-2023 | MCK

Interactive chart of historical net worth (market cap) for McKesson (MCK) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. McKesson net worth as of February 28, 2024 is $68.82B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $68.816B $276.711B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.091B 20.06
Cardinal Health (CAH) United States $27.159B 16.33
West Pharmaceutical Services (WST) United States $26.191B 44.22
Align Technology (ALGN) United States $23.160B 45.89
Cooper (COO) United States $18.783B 29.53
Labcorp (LH) United States $18.065B 15.43
Henry Schein (HSIC) United States $9.939B 17.00
DENTSPLY SIRONA (XRAY) United States $7.055B 18.00
Merit Medical Systems (MMSI) United States $4.628B 26.62
Patterson (PDCO) United States $2.478B 11.48
CONMED (CNMD) United States $2.448B 23.07
STAAR Surgical (STAA) United States $1.542B 48.55
Atrion (ATRI) United States $0.639B 30.05
Lifevantage (LFVN) United States $0.090B 14.60
Pro-Dex (PDEX) United States $0.059B 22.59
Biolase (BIOL) United States $0.003B 0.00